Increased fibulin-1 plasma levels in polycystic ovary syndrome (PCOS) patients: possible contribution to the link between PCOS and cardiovascular risk

被引：0
|
作者：
E. Scarinci
A. Tropea
G. Russo
G. Notaristefano
C. Messana
O. Alesiani
S. M. Fabozzi
A. Lanzone
R. Apa
机构：
[1] Università Cattolica del Sacro Cuore,Department of Obstetrics and Gynecology
[2] Università Cattolica del Sacro Cuore,Department of Cardiovascular Sciences
来源：
Journal of Endocrinological Investigation | 2019年 / 42卷
关键词：
PCOS; Fibulin-1; Cardiovascular risk; Hormonal assay;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：91 / 96
页数：5
相关论文
共 50 条
  • [21] The epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome: The Kaiser Permanente polycystic ovary syndrome (KP-PCOS) study
    Lo, Joan C.
    Feigenbaum, Seth L.
    Yang, Jingrong
    Pressman, Alice R.
    Selby, Joe V.
    Go, Alan S.
    [J]. JOURNAL OF WOMENS HEALTH, 2006, 15 (06) : 679 - 679
  • [22] The Pluripotential Effects of Hypolipidemic Treatment for Polycystic Ovary Syndrome (PCOS): Dyslipidemia, Cardiovascular Risk Factors and Beyond
    Economou, Frangiskos
    Xyrafis, Xenofon
    Christakou, Charikleia
    Diamanti-Kandarakis, Evanthia
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (09) : 908 - 921
  • [23] Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
    Wild, Robert A.
    Carmina, Enrico
    Diamanti-Kandarakis, Evanthia
    Dokras, Anuja
    Escobar-Morreale, Hector F.
    Futterweit, Walter
    Lobo, Rogerio
    Norman, Robert J.
    Talbott, Evelyn
    Dumesic, Daniel A.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (05): : 2038 - 2049
  • [24] Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndrome
    Ademoglu, Esra Nur
    Gorar, Suheyla
    Carlioglu, Ayse
    Yazici, Havva
    Dellal, Fatma Dilek
    Berberoglu, Zehra
    Akdeniz, Derya
    Uysal, Sema
    Karakurt, Feridun
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2014, 37 (08) : 715 - 719
  • [25] Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndrome
    Esra Nur Ademoglu
    Suheyla Gorar
    Ayse Carlıoglu
    Havva Yazıcı
    Fatma Dilek Dellal
    Zehra Berberoglu
    Derya Akdeniz
    Sema Uysal
    Feridun Karakurt
    [J]. Journal of Endocrinological Investigation, 2014, 37 : 715 - 719
  • [26] Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls
    Glintborg, Dorte
    Andersen, Marianne
    Hagen, Claus
    Frystyk, Jan
    Hulstrom, Veronica
    Flyvbjerg, Allan
    Hermann, Anne Pernille
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 155 (02) : 337 - 345
  • [27] Increased PAI-1 levels in women with polycystic ovary syndrome: Evidence for a specific "PCOS effect" independent of age and BMI
    Talbott, EO
    Zborowski, JV
    Guzick, DS
    Meilahn, EN
    Tracy, RP
    McHugh, KP
    Kuller, LH
    [J]. CIRCULATION, 2000, 101 (06) : 716 - 716
  • [28] Increased risk of polycystic ovary syndrome (PCOS) associated with CC genotype of miR-146a gene variation
    Ebrahimi, Seyed Omar
    Reiisi, Somayeh
    Barjui, Shahrbanou Parchami
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2018, 34 (09) : 793 - 797
  • [29] Testing for Insulin Resistance in Polycystic Ovary Syndrome (PCOS) - Fasting Plasma Levels of Glucose and Insulin Is All That Is Needed
    Asante, Albert
    Leonard, Phoebe H.
    Khan, Zaraq
    Jensen, Jani R.
    Elizabeth, Stewart A.
    Charles, Coddington C.
    [J]. REPRODUCTIVE SCIENCES, 2013, 20 (S3) : 177A - 177A
  • [30] Increased Risk for Autism Spectrum Disorders (ASD) in children of mothers suffering from Polycystic Ovary Syndrome (PCOS)
    Krysta, K.
    [J]. EUROPEAN PSYCHIATRY, 2019, 56 : S653 - S653
12345